EMA/European Commission has aproved Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults https://t.co/Fv9DON1AvB https://t.co/Li79tKzMxK
Links:
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucrava…
https://news.bms.com/news/corporate-financial/2026/Bristol-Myers-Squibb-Receive…
May-08-2026
